Clin2
NCT07493577Possibly a fitNot yet recruiting

Testing Tirofiban to Prevent Stroke After Brain Aneurysm Rupture

Aneurysmal Subarachnoid Hemorrhage

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests if a medicine called tirofiban (which helps prevent blood clots) can improve recovery after a brain aneurysm rupture. It is for people who have had their aneurysm treated with a coil and are at risk of a delayed stroke.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
82 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You are between 18 and 85 years old.
  • Your aneurysm was treated with a coil (endovascular coiling) and the doctor says the coiling was complete or nearly complete.
  • Your symptoms from the bleeding started less than 72 hours ago.
  • You are not currently taking blood thinners like aspirin or clopidogrel for a medical condition.
  • You do not have severe kidney disease or are on dialysis.
  • You have not had a major surgery, serious injury, or internal bleeding in the past month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06284642Recruiting· Phase 4
Drain and clot-dissolving medicine for severe aneurysm bleeding

This trial tests whether placing a small drain in the lower back and giving a clot-dissolving medicine (urokinase) into the fluid around the brain can help people recover from a severe bleeding stroke caused by a brain aneurysm. It is for patients who are treated quickly after the bleed.

Hefei, Anhui
NCT07249853Not yet recruiting· Phase 3
Cilostazol for preventing brain injury after aneurysm bleeding

This trial tests whether the drug cilostazol can prevent delayed brain damage in people who have had bleeding from a brain aneurysm. It is for adults who had their aneurysm treated within 72 hours and are in moderate to serious condition.

Beijing, Beijing Municipality
NCT07144956Not yet recruiting· Phase 3
Cilostazol and nimodipine for better recovery after brain aneurysm bleeding

This trial tests whether adding cilostazol to standard nimodipine treatment helps people recover better after a brain aneurysm bursts. Both drugs aim to prevent delayed complications from the bleeding.

NCT06587347Not yet recruiting· Phase 2/Phase 3
Tirofiban to prevent stroke worsening after clot buster

This study tests whether a medication called tirofiban can help prevent stroke symptoms from getting worse after receiving a clot-busting drug. It is for patients with a narrowed brain artery and ongoing moderate to severe symptoms.

Beijing, Beijing Municipality
NCT06319846Recruiting· Phase 3
Tirofiban for recent mild stroke or TIA with narrowed brain artery

This trial tests the drug tirofiban (a blood thinner) to prevent another stroke in people who have had a mild stroke or high-risk TIA and have a narrowed artery in the brain. It must be started within 24 hours of symptoms.

Harbin, Heilongjiang
NCT06373042Not yet recruiting· Phase 2/Phase 3
Tirofiban after successful stroke clot removal

This trial tests if adding a blood thinner called tirofiban after successful clot removal can improve recovery in people with severe stroke. It is for patients who had a large blockage and are treated within 24 hours of symptoms starting.

Hear when a new Aneurysmal Subarachnoid Hemorrhage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.